Search Results 2671-2680 of 18316 for Chronic Lymphocytic Leukemia
We aim to recruit 100 subjects (50 survivors and 50 caregivers) to the study. Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including ...
This designation recognizes the institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.
Phase 4 trials look at long-term ... Current evidence of large cell transformation (LCT), defined as > 25% of the lymphocytes at least 4 × the size of normal ...
... leukemia at the time of screening. Waldenstrom's ... Clinically-not controlled chronic ... Positive for hepatitis B surface antigen (HepBsAg) (indicative of chronic ...
A Study of LNK01002 in Patients With Primary (PMF) or Secondary Myelofibrosis (PV-MF, ET-MF) or Acute Myeloid Leukemia ... Phase 4 trials look at long-term safety ...
Research. Mayo Clinic doctors and scientists are researching ways to improve diagnosis and treatment of acute myelogenous leukemia. Cancer research is conducted ...
... leukemia (AML) who are appropriate for non ... Individuals who have acute promyelocytic leukemia. ... Known active or chronic hepatitis B virus (HBV) ...
Chronic myelogenous leukemia · Diffuse large B-cell lymphoma · Follicular lymphoma · Hairy cell leukemia ... Small lymphocytic lymphoma · Squamous cell carcinoma ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!